Despite mounting evidence on the importance of pain management in preterm infants, clinical use of analgesics in this population is limited. Our previous studies have shown that neonatal inflammation results in long-term alterations in adult somatosensory thresholds, characterized by decreased baseline nociceptive sensitivity, and enhanced hyperalgesia after a subsequent inflammatory insult. The present studies were conducted to determine whether preemptive morphine attenuates these negative consequences. At P0, pups received an injection of morphine sulfate before an intraplantar injection of 1% carrageenan. Control pups received either saline (SAL) followed by intraplantar carrageenan, morphine sulfate followed by intraplantar SAL, or SAL followed by intraplantar SAL. Preemptive morphine significantly attenuated neonatal injuryinduced hypoalgesia in adolescence and adulthood. Similarly, morphine pretreated animals displayed significantly less hyperalgesia and recovered faster from a subsequent inflammatory insult compared with controls. Neonatal morphine had no significant effect on morphine analgesia in adulthood. Interestingly, neonatally injured animals that did not receive morphine displayed a significant rightward shift in the morphine dose-response cuve in the absence of peripheral inflammation. Together, these results demonstrate that preemptive morphine significantly attenuates the long-term behavioral impact of neonatal inflammatory injury. U ntil the late 1980s, many in the medical community believed that neonates were incapable of experiencing pain (1). It is now well established, however, that premature infants are highly responsive to noxious stimulation (2,3) and generate developmentally specific and distinct responses to noxious stimuli (4,5). Nociceptive responses to noxious stimulation have been demonstrated in preterm neonates using an array of physiologic, biochemical, and behavioral measures (6,7). Cortical activation has also been reported in response to noxious stimulation in preterm neonates at 25 wk, suggesting the potential for higher level processing of pain (8,9).Accumulating evidence indicates that exposure to invasive procedures during the neonatal period leads to both short-and long-term alterations in nociceptive processing (10 -13). For example, a higher frequency of invasive procedures in preterm infants has been associated with dampened pain responses at 32 wk of age (14). Decreased facial responsiveness to immunization at 4 and 8 mo (15), and blunted pain sensitivity has also been reported in former preterm neonates (10).Animal studies have also reported that neonatal injury induces long-term alterations in somatic and visceral sensitivity (12,13,16). In particular, animals that received intraplantar carrageenan (CGN) at birth display significant hypoalgesia in the previously injured and uninjured paws in adulthood (12,13). Similar changes in nociceptive sensitivity have also been reported using intraplantar formalin (17). Neonatal injury also results in enhanced hy...